Mulligan Richard bought SANA
June 4, 2026 · Form 4 insider transaction
Mulligan Richard bought 90,000 shares of Sana Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
90,000
Price
$0.00
Total value
N/A
InsiderMulligan Richard
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 5, 2026
Shares owned after90,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.